Source: American Chemical Society (ACS)

Researchers at The Ohio State University College of Veterinary Medicine have identified promising urinary protein biomarkers that could improve early detection and treatment of feline chronic kidney disease (CKD). Published in the Journal of Proteome Research, the study examined urine samples from 30 healthy cats and 34 cats with CKD, identifying more than 2,000 proteins.

One protein, MMP-7, emerged as a potential early-stage biomarker, with elevated levels in affected cats compared with healthy animals. Researchers also identified three distinct protein clusters associated with different forms of advanced CKD, including potentially stable disease, advanced proteinuric disease in younger males, and more unstable late-stage conditions.

Current diagnostic methods often detect CKD only after significant kidney damage has occurred, making earlier identification particularly valuable. The findings suggest that analyzing urinary protein profiles could provide a noninvasive approach to diagnosing and classifying feline CKD, potentially supporting more personalized treatment strategies and improved disease management.

Read the full story HERE: https://www.acs.org/pressroom/presspacs/2026/november/biomarkers-to-diagnose-feline-chronic-kidney-disease.html